Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • CCI slaps fine on two...

    CCI slaps fine on two Gujarat chemists associations

    Written by Ruby Khatun Khatun Published On 2018-01-07T12:30:22+05:30  |  Updated On 7 Jan 2018 12:30 PM IST
    CCI slaps fine on two Gujarat chemists associations

    New Delhi: Clamping down on unfair trade practices in the pharma business, the Competition Commission has imposed a total penalty of over Rs 12 lakh on two Gujarat- based chemists groupings.


    The two associations are Chemists and Druggists Association of Baroda (CDAB) and Federation of Gujarat State Chemists & Druggists Association.


    The Competition Commission of India (CCI), which has been making efforts to sensitise the public on unfair ways in the pharma industry, has also asked the two associations and their respective office bearers to cease and desist from indulging in anti-competitive practices.


    In an order passed on January 4, the fair trade regulator found the CDAB and the Gujarat Federation to be in contravention of the provisions of the Competition Act.


    Accordingly, it slapped a fine of Rs 1.08 lakh and Rs 11.11 lakh on the CDAB and the Federation of Gujarat State Chemists & Druggists Association, respectively, under the provisions of the Competition Act, 2002.


    Besides, the CCI has levied a penalty of Rs 34,048 on CDAB President V T Shah and Rs 62,144 on Gujarat Federation President Jashvant Patel for their anti-competitive practices.


    "Despite several orders of the Commission prescribing the anti-competitive practices of state and regional chemists and druggists associations in, inter alia, mandating NOC (No Objection Certificate) for appointment of stockists and demanding PIS (product information service) charges prior to launching of new drugs in the market, these associations are continuing to indulge in such practices," the regulator noted.


    The Finance Ministry in a tweet said that the CCI will keep a close watch on all such entities.


    "Given the widespread & continuing indulgence in the anti-competitive practices, the Competition Commission of India will be keeping a close watch on the conduct by all such entities in various parts of the country and would not hesitate to take action, wherever deemed necessary," the ministry tweeted.


    "Considering larger public interest involved in the distribution of drugs/medicines, the Competition Commission deprecates such a conduct & its perpetration in any form by those responsible, be it Associations, Stockists/ Distributor/Wholesaler/Retailer & pharmaceutical companies," it added.

    anti-competitive practicesCCIChemists and Druggists Association of BarodaCompetition ActCompetition Commission of IndiaFederation of Gujarat State Chemists and Druggists Associationfinance ministryfineGujarat chemists associationsGujarat Federationpharma businessPharma Industryslapsunfair trade practices
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok